Vanguard Global Advisers’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Vanguard Global Advisers's AMRX Position: Q3 2026 in Review
Vanguard Global Advisers increased its Amneal Pharmaceuticals (AMRX) stake by 10% in Q3 2026, buying an estimated $144K and bringing the position to 88,334 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1333.
Vanguard Global Advisers first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Vanguard Global Advisers held 88,334 shares of Amneal Pharmaceuticals worth $1.78M as of Q3 2026.
- Vanguard Global Advisers bought 8,000 Amneal Pharmaceuticals shares in Q3 2026, an estimated $144K.
- Amneal Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1333 holding.
- Vanguard Global Advisers first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.